• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾地区在 COVID-19 大流行期间传染病负担的变化。

Burden changes in notifiable infectious diseases in Taiwan during the COVID-19 pandemic.

机构信息

Department of Bioenvironmental Systems Engineering, National Taiwan University, Taipei, Taiwan.

Department of Public Health, Chung Shan Medical University, Taichung, Taiwan.

出版信息

PeerJ. 2024 Sep 9;12:e18048. doi: 10.7717/peerj.18048. eCollection 2024.

DOI:10.7717/peerj.18048
PMID:39267943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11391939/
Abstract

BACKGROUND

This study aimed to assess the impact of the COVID-19 pandemic on the disease burden of Taiwan's notifiable infectious diseases (NIDs). We compared disease burdens between the pandemic and pre-pandemic year of 2020 (with non-pharmaceutical interventions (NPIs)) and 2010 (without NPIs), respectively, to understand the overall pandemic impact on NIDs in Taiwan.

METHODS

Forty-three national NIDs were analyzed using the Statistics of Communicable Diseases and Surveillance Report by estimating the premature death and disability different transmission categories, sex, and age groups. The study evaluated the impact of diseases by assessing the years lost due to death (YLLs), the duration of living with disability (YLDs), and the overall disability-adjusted life years (DALYs) by measuring both the severity of the illness and its duration.

RESULTS

Taiwan recorded 1,577 (2010) and 1,260 (2020) DALYs per million population and lost 43 NIDs, decreasing 317 DALYs per million population. Tuberculosis, HIV/AIDS and acute hepatitis B/D were the leading causes of DALYs, accounting for 89% (2010) and 77% (2020).

CONCLUSION

Overall, this study provided the first insight of changes in disease burdens in NIDs between pre- and post-COVID-19 based on a nationwide viewpoint for further preventive measures and interventions to be focused on specific diseases by associated health administrations and policies.

摘要

背景

本研究旨在评估 COVID-19 大流行对台湾法定传染病(NIDs)疾病负担的影响。我们分别比较了大流行年份 2020 年(有非药物干预措施(NPIs))和 2010 年(无 NPIs)的疾病负担,以了解 COVID-19 对台湾 NIDs 的总体影响。

方法

使用传染病统计和监测报告,通过估计不同传播类别的、性别和年龄组的过早死亡和残疾,对 43 种国家法定传染病进行分析。该研究通过评估因疾病导致的死亡而损失的年限(YLLs)、残疾持续时间(YLDs)以及总伤残调整生命年(DALYs),来评估疾病的影响,同时衡量疾病的严重程度及其持续时间。

结果

台湾每百万人口记录了 1577 例(2010 年)和 1260 例(2020 年)的 DALYs,并损失了 43 种 NIDs,每百万人口减少了 317 个 DALYs。结核病、艾滋病毒/艾滋病和急性乙型肝炎/丙型肝炎是 DALYs 的主要原因,占 2010 年的 89%和 2020 年的 77%。

结论

总体而言,这项研究从全国角度首次提供了 COVID-19 前后法定传染病疾病负担变化的见解,以便相关卫生管理部门和政策进一步关注特定疾病的预防措施和干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d4/11391939/9435aa4589aa/peerj-12-18048-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d4/11391939/78071cd32ea2/peerj-12-18048-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d4/11391939/1ef71cf551dd/peerj-12-18048-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d4/11391939/fb1b42ff7291/peerj-12-18048-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d4/11391939/9435aa4589aa/peerj-12-18048-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d4/11391939/78071cd32ea2/peerj-12-18048-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d4/11391939/1ef71cf551dd/peerj-12-18048-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d4/11391939/fb1b42ff7291/peerj-12-18048-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d4/11391939/9435aa4589aa/peerj-12-18048-g004.jpg

相似文献

1
Burden changes in notifiable infectious diseases in Taiwan during the COVID-19 pandemic.台湾地区在 COVID-19 大流行期间传染病负担的变化。
PeerJ. 2024 Sep 9;12:e18048. doi: 10.7717/peerj.18048. eCollection 2024.
2
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
3
Disease burden due to COVID-19 in Taiwan: Disability-adjusted life years (DALYs) with implication of Monte Carlo simulations.台湾地区 COVID-19 疾病负担:应用蒙特卡罗模拟的伤残调整生命年(DALYs)
J Infect Public Health. 2023 Jun;16(6):884-892. doi: 10.1016/j.jiph.2023.03.028. Epub 2023 Mar 29.
4
The impact of COVID-19 on the epidemiology of non-airborne/droplet-transmitted notifiable infectious diseases in Taiwan: A descriptive study.COVID-19 对台湾非空气传播/飞沫传播传染病流行病学的影响:描述性研究。
J Infect Public Health. 2022 Sep;15(9):1001-1005. doi: 10.1016/j.jiph.2022.08.001. Epub 2022 Aug 4.
5
National disability-adjusted life years (DALYs) for 257 diseases and injuries in Ethiopia, 1990-2015: findings from the global burden of disease study 2015.1990 - 2015年埃塞俄比亚257种疾病和损伤的全国残疾调整生命年(DALYs):全球疾病负担研究2015的结果
Popul Health Metr. 2017 Jul 21;15(1):28. doi: 10.1186/s12963-017-0146-0.
6
Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.2019 年与 85 种病原体相关的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet Infect Dis. 2024 Aug;24(8):868-895. doi: 10.1016/S1473-3099(24)00158-0. Epub 2024 Apr 16.
7
The Burden of Disease due to COVID-19 in Korea Using Disability-Adjusted Life Years.使用伤残调整生命年来衡量韩国 COVID-19 疾病负担。
J Korean Med Sci. 2020 Jun 1;35(21):e199. doi: 10.3346/jkms.2020.35.e199.
8
Disability-adjusted life years (DALYs) due to the direct health impact of COVID-19 in India, 2020.2020 年印度因 COVID-19 直接健康影响导致的伤残调整生命年(DALYs)。
Sci Rep. 2022 Feb 14;12(1):2454. doi: 10.1038/s41598-022-06505-z.
9
Estimating the disability adjusted life years associated with COVID-19 in Iran for the first 2 years of the pandemic.估算伊朗在新冠疫情大流行的头两年中与新冠病毒病相关的伤残调整生命年。
Front Public Health. 2024 Jan 11;11:1303549. doi: 10.3389/fpubh.2023.1303549. eCollection 2023.
10
Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic.中国 COVID-19 大流行前后 24 种法定传染病的时间变化。
Nat Commun. 2024 May 8;15(1):3891. doi: 10.1038/s41467-024-48201-8.

本文引用的文献

1
Persistence and Variation of the Indirect Effects of COVID-19 Restrictions on the Spectrum of Notifiable Infectious Diseases in China: Analysis of National Surveillance Among Children and Adolescents From 2018 to 2021.COVID-19 限制措施对中国法定传染病谱的间接影响的持续性和变化:2018 年至 2021 年对儿童和青少年进行的全国监测分析。
JMIR Public Health Surveill. 2024 May 15;10:e47626. doi: 10.2196/47626.
2
Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic.中国 COVID-19 大流行前后 24 种法定传染病的时间变化。
Nat Commun. 2024 May 8;15(1):3891. doi: 10.1038/s41467-024-48201-8.
3
How Taiwan has responded to COVID-19 and how COVID-19 has affected Taiwan, 2020-2022.
2020-2022 年台湾地区应对 COVID-19 疫情的措施和 COVID-19 疫情对台湾地区的影响。
J Microbiol Immunol Infect. 2023 Jun;56(3):433-441. doi: 10.1016/j.jmii.2023.04.001. Epub 2023 Apr 6.
4
Non-pharmaceutical interventions for COVID-19 reduced the incidence of infectious diseases: a controlled interrupted time-series study.非药物干预措施降低了 COVID-19 传染病发病率:一项基于对照的中断时间序列研究。
Infect Dis Poverty. 2023 Mar 9;12(1):15. doi: 10.1186/s40249-023-01066-3.
5
Impact of the COVID-19 pandemic on the epidemiology of other communicable diseases in Japan.新冠疫情对日本其他传染病流行病学的影响。
Int J Infect Dis. 2023 Mar;128:265-271. doi: 10.1016/j.ijid.2023.01.013. Epub 2023 Jan 13.
6
Long-term benefits of nonpharmaceutical interventions for endemic infections are shaped by respiratory pathogen dynamics.非药物干预措施对地方病感染的长期效益受呼吸道病原体动态的影响。
Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2208895119. doi: 10.1073/pnas.2208895119. Epub 2022 Nov 29.
7
The impact of COVID-19 on the epidemiology of non-airborne/droplet-transmitted notifiable infectious diseases in Taiwan: A descriptive study.COVID-19 对台湾非空气传播/飞沫传播传染病流行病学的影响:描述性研究。
J Infect Public Health. 2022 Sep;15(9):1001-1005. doi: 10.1016/j.jiph.2022.08.001. Epub 2022 Aug 4.
8
Disability adjusted life years associated with COVID-19 in Denmark in the first year of the pandemic.大流行第一年丹麦与 COVID-19 相关的残疾调整生命年。
BMC Public Health. 2022 Jul 9;22(1):1315. doi: 10.1186/s12889-022-13694-9.
9
Time-to-Disability Determinants Among Leprosy Patients Enrolled for Treatment at ALERT Center, Addis Ababa, Ethiopia: A Survival Analysis.埃塞俄比亚亚的斯亚贝巴ALERT中心接受治疗的麻风病患者致残时间的决定因素:一项生存分析
Infect Drug Resist. 2022 May 30;15:2729-2741. doi: 10.2147/IDR.S361799. eCollection 2022.
10
The Collateral Effect of COVID-19 on the Epidemiology of Airborne/Droplet-Transmitted Notifiable Infectious Diseases in Taiwan.COVID-19对台湾空气传播/飞沫传播法定传染病流行病学的附带影响。
Antibiotics (Basel). 2022 Apr 3;11(4):478. doi: 10.3390/antibiotics11040478.